EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Hospital General de Granollers
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de Granollers (2)
2020
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4
2018
-
Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii64